Evidence for the activation of blood complement in Sephadex beads-induced lung inflammation in guinea pigs

被引:3
作者
Blain, JF [1 ]
Maghni, K [1 ]
Pelletier, S [1 ]
Sirois, P [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada
基金
英国医学研究理事会;
关键词
complement; eosinophils; non-immunologic stimulus; anaphylatoxin;
D O I
10.1007/s000110050476
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective and Design: This study evaluated the complement activation in guinea pigs that were given an intravenous injection of Sephadex and its correlation with markers of the development of inflammation. Materials and Methods: Dunkin Hartley guinea pigs (250-300 g) were used. Whole blood was collected by heart puncture in a sodium citrate solution (0.315 g/ml) for complement measurements. Complement activation was measured using a colorimetric haemolytic assay. Bronchoalveolar lavages (BAL) were performed to monitor cell infiltration and inflammation was monitored by measurements of eosinophil peroxidase (EPO), histamine, beta-glucuronidase, albumin and total proteins in the BAL fluid. Treatment: Guinea pigs were pre-treated with aprotinin (40 000 IKU/kg) 30 min before they were given an intravenous injection of Sephadex beads (24 mg/kg). Carboxymethyl (CM)-Sephadex (24 mg/kg) was administered alone. Results: Sephadex beads activated the complement system in vitro (14.12 +/- 2.29 U/ml) and in vivo (9.95 +/- 0.08 U/ml) reaching a peak 6 h after the injection. This activation was accompanied by other characteristic features of inflammation such as leukocyte infiltration and activation. Both CM-Sephadex and aprotinin reduced the blood complement activation and eosinophil infiltration/activation observed. Conclusions: Our results strongly suggest that complement is involved in the cascade of events leading to the inflammatory state observed in guinea pig following the intravenous injection of Sephadex beads.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 33 条
[1]   STUDIES OF IN VIVO BEHAVIOR OF HUMAN C'3 IN NORMAL SUBJECTS AND PATIENTS [J].
ALPER, CA ;
ROSEN, FS .
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (12) :2021-&
[2]  
AUSTEN KF, 1974, TRANSPLANT P, V6, P39
[3]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   COMPLEMENT METABOLISM IN MAN - HYPERCATABOLISM OF FOURTH (C4) AND THIRD (C3) COMPONENTS IN PATIENTS WITH RENAL ALLOGRAFT REJECTION AND HEREDITARY ANGIOEDEMA (HAE) [J].
CARPENTER, CB ;
RUDDY, S ;
SHEHADEH, IH ;
MULLEREB.HJ ;
MERRILL, JP ;
AUSTEN, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (08) :1495-+
[6]   THE ABILITY OF SEPHADEX TO ACTIVATE HUMAN-COMPLEMENT IS SUPPRESSED IN SPECIFICALLY SUBSTITUTED FUNCTIONAL SEPHADEX DERIVATIVES [J].
CARRENO, MP ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
MOLECULAR IMMUNOLOGY, 1988, 25 (02) :165-171
[7]   SPECIFIC ANTIBODIES ENHANCE SEPHADEX-INDUCED ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY IN HUMAN-SERUM [J].
CARRENO, MP ;
MAILLET, F ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
BIOMATERIALS, 1988, 9 (06) :514-518
[8]   COMPLEMENT ACTIVATION BY HOUSE DUST - REDUCED REACTIVITY OF SERUM COMPLEMENT IN PATIENTS WITH BRONCHIAL-ASTHMA [J].
CASTRO, FFM ;
SCHMITZSCHUMANN, M ;
ROTHER, U ;
KIRSCHFINK, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 96 (04) :305-310
[9]   COMPLEMENT ACTIVATION DURING HEMODIALYSIS - CLINICAL OBSERVATIONS, PROPOSED MECHANISMS, AND THEORETICAL IMPLICATIONS [J].
CHENOWETH, DE .
ARTIFICIAL ORGANS, 1984, 8 (03) :281-287
[10]   C3A IS A CHEMOTAXIN FOR HUMAN EOSINOPHILS BUT NOT FOR NEUTROPHILS .1. C3A STIMULATION OF NEUTROPHILS IS SECONDARY TO EOSINOPHIL ACTIVATION [J].
DAFFERN, PJ ;
PFEIFER, PH ;
EMBER, JA ;
HUGLI, TE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2119-2127